Rakhit Amit 4
4 · Ovid Therapeutics Inc. · Filed Nov 4, 2019
Insider Transaction Report
Form 4
Rakhit Amit
CMO and PMO
Transactions
- Award
Common Stock (right to buy)
2019-11-01+75,000→ 75,000 totalExercise: $2.46Exp: 2029-10-31→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the Stock Option will vest and become exercisable on November 1, 2020 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date.